Amivantamab

Browsing: Amivantamab

Conferences

ESMO 2020: Amivantamab with lazertinib in patients with EGFR-mutated non-small cell lung cancer

September 22, 2020

The CHRYSALIS study (NCT02609776) is evaluating amivantamab, a fully human bispecific antibody that targets epidermal…

Subscribe for News Updates
Search Oncology News
Search for:
Speak your mind!

Passionate about a development that deserves more attention? Views on a controversial issue?

Oncology News publishes commentary pieces from oncology professionals here and in The Oncology Newsletter.

Contact us to discuss
Subscribe for News Updates

The Oncology Newsletter is a free publication distributed to healthcare professionals every week, featuring news, views, reviews and the latest jobs. Subscribe.
About Us

Oncology News Australia is a small group of publishing, media and digital professionals providing resources for the oncology community. More information.
Advertising with Us

If you seek to connect and present your product or service to an engaged oncology healthcare community, you have come to the right place. More information.
© Oncology News Australia | info@oncologynews.com.au